Search results: The pahtway p3243 has 68 genes in the original annotation. Currently, there are 44 genes in SZGR 2.0 (with evidence in schizophrenia) that are present at this pathway.

Because the gene page contains a lot of information, it takes on average 3-5 seconds to load. So when you click a gene ID, please be patient for the page to load.

Gene ID Symbol Synonyms Official Full Name Location SZ group ? Functional group ?
3688ITGB1CD29 | FNRB | GPIIA | MDF2 | MSK12 | VLA-BETA | VLABintegrin subunit beta 110p11.2CV:GWASdb
CV:PGCnp
GO_Annotation
Network
6251RSU1RSP-1Ras suppressor protein 110p13CV:PGCnp
DMG:Wockner_2014
132ADKAKadenosine kinase10q22|10q11-q24CV:PGCnp
PMID:cooccur
6881TAF10TAF2A | TAF2H | TAFII30TATA-box binding protein associated factor 1011p15.3CV:PGCnp
8519IFITM19-27 | CD225 | DSPA2a | IFI17 | LEU13interferon induced transmembrane protein 111p15.5DMG:Montano_2016
Expression
PMID:cooccur
283120H19ASM | ASM1 | BWS | D11S813E | LINC00008 | NCRNA00008 | WT2H19, imprinted maternally expressed transcript (non-protein coding)11p15.5CV:PGCnp
PMID:cooccur
6947TCN1HC | TC-1 | TC1 | TCItranscobalamin 111q11-q12CV:PGCnp
DMG:vanEijk_2014
4312MMP1CLG | CLGNmatrix metallopeptidase 111q22.3PMID:cooccur
10970CKAP4CLIMP-63 | ERGIC-63 | p63cytoskeleton-associated protein 412q23.3CV:PGCnp
DMG:vanEijk_2014
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-CONSENSUS
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-FULL
G2Cdb.human_BAYES-COLLINS-MOUSE-PSD-CONSENSUS
CompositeSet
Ascano FMRP targets
2098ESDFGHesterase D13q14.1-q14.2Association
CV:PGCnp
PMID:cooccur
1033CDKN3CDI1 | CIP2 | KAP | KAP1cyclin-dependent kinase inhibitor 314q22CV:GWAScat
CV:GWASdb
CV:PGCnp
DNM:Kranz_2015
PMID:cooccur
4522MTHFD1MTHFC | MTHFDmethylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase14q24Association
DMG:Jaffe_2016
DMG:Wockner_2014
PMID:cooccur
Ascano FMRP targets
5479PPIBCYP-S1 | CYPB | HEL-S-39 | OI9 | SCYLPpeptidylprolyl isomerase B15q21-q22CV:PGCnp
Network
RNA AND PROTEIN SYNTHESIS
G2Cdb.humanPSD
G2Cdb.humanPSP
9768KIAA0101L5 | NS5ATP9 | OEATC | OEATC-1 | OEATC1 | PAF | PAF15 | p15(PAF) | p15/PAF | p15PAFKIAA010115q22.31CV:PGCnp
3418IDH2D2HGA2 | ICD-M | IDH | IDHM | IDP | IDPM | mNADP-IDHisocitrate dehydrogenase 2 (NADP+), mitochondrial15q26.1CV:PGCnp
DMG:Jaffe_2016
G2Cdb.human_mitochondria
G2Cdb.humanPSD
G2Cdb.humanPSP
CompositeSet
Chromatin Remodeling Genes
4493MT1EMT-1E | MT-IE | MT1 | MTDmetallothionein 1E16q13CV:PGCnp
DMG:Wockner_2014
PMID:cooccur
4501MT1XMT-1l | MT1metallothionein 1X16q13CV:PGCnp
DMG:Wockner_2014
PMID:cooccur
16AARSCMT2N | EIEE29alanyl-tRNA synthetase16q22CV:PGCnp
DMG:vanEijk_2014
CompositeSet
Ascano FMRP targets
6510SLC1A5AAAT | ASCT2 | ATBO | M7V1 | M7VS1 | R16 | RDRCsolute carrier family 1 member 519q13.3CV:PGCnp
DMG:Wockner_2014
PMID:cooccur
991CDC20CDC20A | bA276H19.3 | p55CDCcell division cycle 201p34.1CV:PGCnp
Network
PMID:cooccur
8565YARSCMTDIC | TYRRS | YRS | YTStyrosyl-tRNA synthetase1p35.1CV:PGCnp
DNM:Fromer_2014
CompositeSet
3925STMN1C1orf215 | LAP18 | Lag | OP18 | PP17 | PP19 | PR22 | SMNstathmin 11p36.11CV:PGCnp
GO_Annotation
PMID:cooccur
STRUCTURAL PLASTICITY
5226PGD6PGDphosphogluconate dehydrogenase1p36.22CV:PGCnp
DMG:Wockner_2014
Network
PMID:cooccur
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-CONSENSUS
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-FULL
CompositeSet
5321PLA2G4APLA2G4 | cPLA2 | cPLA2-alphaphospholipase A2 group IVA1q31.1Association
CV:PGCnp
GO_Annotation
GR_Ng
GR_WM
PMID:cooccur
G2Cdb.humanNRC
G2Cdb.humanPSP
11065UBE2CUBCH10 | dJ447F3.2ubiquitin conjugating enzyme E2 C20q13.12CV:PGCnp
DMG:Wockner_2014
873CBR1CBR | SDR21C1 | hCBR1carbonyl reductase 121q22.13DEG:Zhao_2015
Network
CompositeSet
7494XBP1TREB-5 | TREB5 | XBP-1 | XBP2X-box binding protein 122q12.1|22q12Association
CV:PGCnp
DEG:Sanders_2013
DMG:Jaffe_2016
GR_Ng
GR_WM
GSMA_I
PMID:cooccur
3976LIFCDF | DIA | HILDA | MLPLIleukemia inhibitory factor22q12.2CV:PGCnp
GSMA_I
PMID:cooccur
6382SDC1CD138 | SDC | SYND1 | syndecansyndecan 12p24.1CV:GWAScat
CV:PGCnp
DEG:Sanders_2013
Network
7447VSNL1HLP3 | HPCAL3 | HUVISL1 | VILIP | VILIP-1visinin like 12p24.3CV:PGCnp
PMID:cooccur
INTRACELLULAR SIGNAL TRANSDUCTION
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-CONSENSUS
CompositeSet
4953ODC1ODCornithine decarboxylase 12p25CV:PGCnp
DMG:Nishioka_2013
3655ITGA6CD49f | ITGA6B | VLA-6integrin subunit alpha 62q31.1CV:PGCnp
DMG:Nishioka_2013
DNM:Ambalavanan_2016
DNM:Xu_2012
Expression
PMID:cooccur
CompositeSet
5757PTMATMSAprothymosin, alpha2q37.1CV:PGCnp
DMG:Jaffe_2016
4292MLH1COCA2 | FCC2 | HNPCC | HNPCC2 | hMLH1mutL homolog 13p21.3CV:PGCnp
GSMA_I
5333PLCD1NDNC3 | PLC-IIIphospholipase C delta 13p22-p21.3CV:PGCnp
DMG:Wockner_2014
GSMA_I
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-FULL
483ATP1B3ATPB-3 | CD298ATPase Na+/K+ transporting subunit beta 33q23CV:PGCnp
DMG:Wockner_2014
6715SRD5A1S5AR 1steroid 5 alpha-reductase 15p15CV:PGCnp
PMID:cooccur
5066PAMPAL | PHMpeptidylglycine alpha-amidating monooxygenase5q14-q21CV:GWASdb
CV:PGCnp
Expression
GR_Ng
PMID:cooccur
3181HNRNPA2B1HNRNPA2 | HNRNPB1 | HNRPA2 | HNRPA2B1 | HNRPB1 | IBMPFD2 | RNPA2 | SNRPB1heterogeneous nuclear ribonucleoprotein A2/B17p15CV:PGCnp
440ASNSASNSD | TS11asparagine synthetase (glutamine-hydrolyzing)7q21.3CV:PGCnp
DMG:Jaffe_2016
GO_Annotation
1052CEBPDC/EBP-delta | CELF | CRP3 | NF-IL6-betaCCAAT/enhancer binding protein delta8p11.2-p11.1CV:PGCnp
DMG:Nishioka_2013
PMID:cooccur
2053EPHX2CEH | SEHepoxide hydrolase 28p21CV:GWAScat
CV:GWASdb
CV:PGC128
CV:PGCnp
GSMA_I
GSMA_IIA
GSMA_IIE
2934GSNADF | AGELgelsolin9q33CV:GWAScat
CV:GWASdb
CV:PGCnp
DMG:Wockner_2014
PMID:cooccur
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-CONSENSUS
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-FULL
G2Cdb.humanNRC
CompositeSet
Potential synaptic genes
3309HSPA5BIP | GRP78 | HEL-S-89n | MIF2heat shock protein family A (Hsp70) member 59q33.3CV:PGCnp
Network
PMID:cooccur
RNA AND PROTEIN SYNTHESIS
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-CONSENSUS
G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-FULL
G2Cdb.human_BAYES-COLLINS-MOUSE-PSD-CONSENSUS
G2Cdb.human_clathrin
G2Cdb.human_Synaptosome
G2Cdb.humanPSD
G2Cdb.humanPSP
CompositeSet
Ascano FMRP targets